oxytetracycline hydrochloride
intervet australia pty limited - oxytetracycline hydrochloride - unknown - oxytetracycline hydrochloride antibiotic active 0.0 - active constituent
oxytetracycline hydrochloride
abbey laboratories pty ltd - oxytetracycline hydrochloride - unknown - oxytetracycline hydrochloride antibiotic active 0.0 - active constituent
oxytetracycline dihydrate
norbrook laboratories australia pty limited - oxytetracycline dihydrate - unknown - oxytetracycline dihydrate antibiotic active 0.0 - active constituent
oxytetracycline hydrochloride
norbrook laboratories australia pty limited - oxytetracycline hydrochloride - unknown - oxytetracycline hydrochloride antibiotic active 0.0 - active constituent
oxytetracycline dihydrate
boehringer ingelheim animal health australia pty. ltd. - oxytetracycline dihydrate - unknown - oxytetracycline dihydrate antibiotic active 0.0 - active constituent
oxytetracycline hydrochloride
ccd animal health pty ltd - oxytetracycline hydrochloride - unknown - oxytetracycline hydrochloride antibiotic active 0.0 - active constituent
oxytetracycline hydrochloride
mavlab pty. ltd. - oxytetracycline hydrochloride - unknown - oxytetracycline hydrochloride antibiotic active 0.0 - active constituent
urobiotic- oxytetracycline hydrochloride, sulfamethizole and phenazopyridine hydrochloride capsule
roerig - oxytetracycline hydrochloride (unii: 4u7k4n52zm) (oxytetracycline - unii:x20i9en955, oxytetracycline - unii:x20i9en955, oxytetracycline - unii:x20i9en955), sulfamethizole (unii: 25w8454h16) (sulfamethizole - unii:25w8454h16, sulfamethizole - unii:25w8454h16, sulfamethizole - unii:25w8454h16), phenazopyridine hydrochloride (unii: 2iuy41693z) (phenazopyridine - unii:, phenazopyridine - unii:, phenazopyridine - unii:) - capsule - based on a review of this drug by the national academy of sciences-national research council and/or other information, fda has classified the indications as follows: "lacking substantial evidence of effectiveness as a fixed combination": urobiotic-250 is indicated in the therapy of a number of genitourinary infections caused by susceptible organisms. these infections include the following: pyelonephritis, pyelitis, ureteritis, cystitis, prostatitis, and urethritis. since both terramycin and sulfamethizole provide effective levels in blood, tissue, and urine, urobiotic-250 provides a multiple antimicrobial approach at the site of infection. both antibacterial components are active against the most common urinary pathogens, including escherichia coli, pseudomonas aeruginosa, aerobacter aerogenes, streptococcus faecalis, streptococcus hemolyticus , and micrococcus pyogenes . urobiotic-250 is particularly useful in the treatment of infections caused by bacteria more sensitive to the combination than to either com
bota-oxy 5 wsp oral powder in sachet
oxytetracycline hcl - oral powder in sachet - oxytetracycline 50mg - tetracycline
tetravet 100 soluble antibiotic powder
elanco new zealand - oxytetracycline hydrochloride - oxytetracycline hydrochloride 100 g/kg - antibiotic